Janet R. Vos

Mutational Signature Analysis Reveals NTHL1 Deficiency to Cause a Multi-tumor Phenotype

Judith E. Grolleman, Richarda M. de Voer, Fadwa A. Elsayed et al. · Cancer Cell · 2019 · 175 citations · Full text

Medicine, Molecular Biology, Molecular Genetics +12

Cancer Surveillance Guideline for individuals with PTEN hamartoma tumour syndrome

Marc Tischkowitz, Chrystelle Colas, Sjaak Pouwels et al. · European Journal of Human Genetics · 2020 · 135 citations · Full text

Medicine, Gynecology, Oncology +15

Universal Tumor DNA BRCA1/2 Testing of Ovarian Cancer: Prescreening PARPi Treatment and Genetic Predisposition

Janet R. Vos, Ingrid E. Fakkert, Joanne A. de Hullu et al. · JNCI Journal of the National Cancer Institute · 2019 · 69 citations · Full text

Medicine, Genetics, Oncology +17

Cancer risks by sex and variant type in PTEN hamartoma tumor syndrome

Linda A.J. Hendricks, Nicoline Hoogerbrugge, Arjen R. Mensenkamp et al. · JNCI Journal of the National Cancer Institute · 2022 · 50 citations · Full text

Medicine, Cancer Biology, Oncology +17

Genomic reanalysis of a pan-European rare-disease resource yields new diagnoses

Steven Laurie, Kiran Polavarapu, Nika Schuermans et al. · Nature Medicine · 2025 · 47 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17